文献速递心脑血管急症消化、代谢与肾脏急症

Stroke Ready 社区参与式研究干预与密歇根州弗林特市急性卒中溶栓发生率的相关性

Association of the Stroke Ready Community-Based Participatory Research Intervention With Incidence of Acute Stroke Thrombolysis in Flint, Michigan.
PubMed 文献 · JAMA Netw Open · 2023-07-03
一句话结论在弗林特开展的多层面急诊科与社区卒中准备干预整体上与溶栓使用增加无关,但急诊科部分与溶栓使用增加相关(校正OR 1.63)。

该非随机对照试验在密歇根州弗林特市于2017年10月至2020年3月实施Stroke Ready干预,结合实施科学与社区参与式研究,先优化安全网医院急诊科急性卒中诊疗,再开展社区范围理论健康行为干预(同伴主导工作坊、邮件、社交媒体)。预设主要终点为干预前后弗林特市因缺血性卒中或短暂性脑缺血发作住院患者接受溶栓的比例。共3327例次就诊(女性1848例[55.6%],黑人1747例[52.5%],平均年龄67.8[14.5]岁),溶栓比例从2010年4%升至2020年14%;联合干预与溶栓使用无关(校正OR 1.13;95%CI 0.74-1.70;P=.58),急诊科部分与溶栓使用增加相关(校正OR 1.63;95%CI 1.04-2.56;P=.03),社区部分无关(校正OR 0.99;95%CI 0.96-1.01;P=.30)。作者认为与安全网医院合作实施策略可能增加溶栓使用。

要点

  • 联合急诊科与社区干预整体与溶栓使用无关:校正OR 1.13(95%CI 0.74-1.70;P=.58)。
  • 急诊科干预部分与溶栓使用增加相关:校正OR 1.63(95%CI 1.04-2.56;P=.03)。
  • 社区干预部分与溶栓使用无关:校正OR 0.99(95%CI 0.96-1.01;P=.30)。
  • 5970人参加面对面卒中准备 workshops,相当于弗林特成人人口的9.7%。
  • 溶栓使用比例从2010年4%升至2020年14%。

适用人群与场景

  • 密歇根州弗林特市社区成年居民;分析纳入弗林特市因缺血性卒中或短暂性脑缺血发作在相关急诊科就诊的3327例次(女性1848例[55.6%],黑人1747例[52.5%],平均年龄67.8[14.5]岁)。

处置流程与药物剂量

  • Stroke Ready干预:先在安全网医院急诊科优化急性卒中诊疗,再开展社区范围理论健康行为干预,包括同伴主导工作坊、邮件和社交媒体;5970人参加面对面卒中准备 workshops,相当于弗林特成人人口的9.7%。

研究设计与关键结果

  • 非随机对照试验,2017年10月至2020年3月在密歇根州弗林特市实施;数据分析于2022年7月至2023年5月完成。
  • 预设主要终点为弗林特市因缺血性卒中或短暂性缺血发作住院患者干预前后接受溶栓的比例;采用逻辑回归模型估计联合干预与溶栓的关联,按医院水平聚类并校正时间和卒中类型。
  • 共3327例次缺血性卒中和短暂性脑缺血发作就诊,其中干预前(2010年7月至2017年9月)2305例次,干预后(2017年10月至2020年3月)1022例次。
  • 溶栓使用比例从2010年4%升至2020年14%。
  • 联合Stroke Ready干预与溶栓使用无关:校正OR 1.13(95%CI 0.74-1.70;P=.58)。
  • 预设次要分析中,急诊科部分与溶栓使用增加相关:校正OR 1.63(95%CI 1.04-2.56;P=.03);社区部分与溶栓使用无关:校正OR 0.99(95%CI 0.96-1.01;P=.30);均校正医院、时间和卒中类型。

证据类型、等级与局限

  • 证据类型:非随机对照试验(ClinicalTrials.gov标识NCT036455900)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与安全网医院合作实施策略可能增加溶栓使用;急诊科干预部分与溶栓使用增加相关,而联合干预及社区部分未显示与溶栓使用增加相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Acute stroke treatment rates in the US lag behind those in other high-income nations.

OBJECTIVE: To assess whether a hospital emergency department (ED) and community intervention was associated with an increased proportion of patients with stroke receiving thrombolysis.

DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled trial of the Stroke Ready intervention took place in Flint, Michigan, from October 2017 to March 2020. Participants included adults living in the community. Data analysis was completed from July 2022 to May 2023.

INTERVENTION: Stroke Ready combined implementation science and community-based participatory research approaches. Acute stroke care was optimized in a safety-net ED, and then a community-wide, theory-based health behavior intervention, including peer-led workshops, mailers, and social media, was conducted.

MAIN OUTCOMES AND MEASURES: The prespecified primary outcome was the proportion of patients hospitalized with ischemic stroke or transient ischemic attack from Flint who received thrombolysis before and after the intervention. The association between thrombolysis and the Stroke Ready combined intervention, including the ED and community components, was estimated using logistic regression models, clustering at the hospital level and adjusting for time and stroke type. In prespecified secondary analyses, the ED and community intervention were explored separately, adjusting for hospital, time, and stroke type.

RESULTS: In total, 5970 people received in-person stroke preparedness workshops, corresponding to 9.7% of the adult population in Flint. There were 3327 ischemic stroke and TIA visits (1848 women [55.6%]; 1747 Black individuals [52.5%]; mean [SD] age, 67.8 [14.5] years) among patients from Flint seen in the relevant EDs, including 2305 in the preintervention period from July 2010 to September 2017 and 1022 in the postintervention period from October 2017 to March 2020. The proportion of thrombolysis usage increased from 4% in 2010 to 14% in 2020. The combined Stroke Ready intervention was not associated with thrombolysis use (adjusted odds ratio [OR], 1.13; 95% CI, 0.74-1.70; P = .58). The ED component was associated with an increase in thrombolysis use (adjusted OR, 1.63; 95% CI, 1.04-2.56; P = .03), but the community component was not (adjusted OR, 0.99; 95% CI, 0.96-1.01; P = .30).

CONCLUSIONS AND RELEVANCE: This nonrandomized controlled trial found that a multilevel ED and community stroke preparedness intervention was not associated with increased thrombolysis treatments. The ED intervention was associated with increased thrombolysis usage, suggesting that implementation strategies in partnership with safety-net hospitals may increase thrombolysis usage.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT036455900.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Skolarus LE, Bailey S, Corches CL, et al. Association of the Stroke Ready Community-Based Participatory Research Intervention With Incidence of Acute Stroke Thrombolysis in Flint, Michigan. JAMA Netw Open. 2023. PMID: 37399011. doi:10.1001/jamanetworkopen.2023.21558

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。